Twin Focus Capital Partners, LLC Vbi Vaccines Inc Transaction History

Twin Focus Capital Partners, LLC

  • $625 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 10, 2018
SELL
$2.75 - $3.85 $55,662 - $77,927
-20,241 Closed
0 $0
Q3 2017

Nov 13, 2017
BUY
$3.15 - $4.01 $63,759 - $81,166
20,241
20,241 $78,000

Others Institutions Holding VBIV

# of Institutions
2
Shares Held
688K
Call Options Held
0
Put Options Held
0
View Full List

About VBI Vaccines Inc

VBIV Quotes by TradingView
  • Ticker VBIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 258,256,992
  • Market Cap $5.17M
  • Description
  • VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...
More about VBIV
Track This Portfolio

Track Twin Focus Capital Partners, LLC Portfolio

Follow Twin Focus Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Focus Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Twin Focus Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email